IL-2, a cytokine playing a pivotal role during chronic HCV infection, showed a similar expression in HCV and NASH patients (p = 0.77) but was virtually absent in NAFLD. This evidence concerns the gene IL2 and metabolic dysfunction-associated steatohepatitis.